Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
completed

Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus

NCT02801812
unknownnot_applicable

Low-field Magnetic Resonance Imaging in Pediatric Post Covid-19

NCT05445531
unknown

NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity

NCT05106998
completedphase_4

Nailfold Capillary Blood Flow With Latanoprost Bunod

NCT03949244

Clinical Trials (4)

Showing 4 of 4 trials
NCT02801812

Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus

Completed
NCT05445531Not Applicable

Low-field Magnetic Resonance Imaging in Pediatric Post Covid-19

Unknown
NCT05106998

NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity

Unknown
NCT03949244Phase 4

Nailfold Capillary Blood Flow With Latanoprost Bunod

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4